Single Use of Itraconazole Has No Effect on Treatment for Penicillium Marneffei with HIV Infection.
暂无分享,去创建一个
L. Ye | B. Liang | Junjun Jiang | Hao Liang | Jiegang Huang | Gu Ying | Qi-jian Su
[1] P. Horby,et al. Clinical characteristics and outcome of Penicillium marneffei infection among HIV-infected patients in northern Vietnam , 2012, AIDS Research and Therapy.
[2] D. Tsang,et al. Clinical presentations and outcomes of Penicillium marneffei infections: a series from 1994 to 2004. , 2008, Hong Kong medical journal = Xianggang yi xue za zhi.
[3] M. Mileno,et al. Penicillium marneffei infection in HIV-infected travelers. , 2006, AIDS alert.
[4] E. Mylonakis,et al. Antifungal use in HIV infection , 2002, Expert opinion on pharmacotherapy.
[5] K. Nelson,et al. A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] K. Nelson,et al. A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus. , 1998, The New England journal of medicine.
[7] K. Nelson,et al. Amphotericin B and itraconazole for treatment of disseminated Penicillium marneffei infection in human immunodeficiency virus-infected patients. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] T. Duong,et al. Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] K. Nelson,et al. Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens , 1993, Antimicrobial Agents and Chemotherapy.